Literature DB >> 7779704

Increased thymidylate synthase protein levels are principally associated with proliferation but not cell cycle phase in asynchronous human cancer cells.

B C Pestalozzi1, C J McGinn, T J Kinsella, J C Drake, M C Glennon, C J Allegra, P G Johnston.   

Abstract

We have analysed cell cycle variations in thymidylate synthase (TS) protein in asynchronously growing NCl H630 and HT 29 colon cancer and MCF-7 breast cancer cell lines. Western immunoblot analysis using the TS 106 monoclonal antibody revealed a 14- to 24-fold variation in TS levels between the peak exponential and confluent growth phase in the three cell lines. Similar variations in TS levels and TS activity were detected using the 5-fluorodeoxyuridine monophosphate and deoxyuridine monophosphate biochemical assays. The percentage of cells in S-phase, which paralleled changes in TS levels, reached a maximum of 38-60% in asynchronous exponentially growing cells compared with 5-10% in confluent cells. In asynchronous exponential cells, analysis of TS levels in each cell cycle phase using two-parameter flow cytometric analysis revealed that TS protein levels were 1.3- to 1.5-fold higher in S than in G0/G1 phase cells, and 1.5- to 1.8-fold higher in G2/M than G0/G1 cells. Similar differences of 1.1- to 1.5-fold between G0/G1 and S-phase and 1.6- to 1.9-fold between G0/G1 and G2/M-phase were detected by Western immunoblot and biochemical assays. TS protein was not detectable by Western blot analysis, flow cytometry or biochemical analysis in the G0/G1 population of confluent cells. Twenty-six per cent of cells in this population were G0 cells compared with 2% in exponentially growing cells. In contrast to TS, a 4-fold difference in thymidine kinase (TK) was detected between G0/G1 and S-phase cells in exponentially growing MCF-7 cells. The level of TS enzyme is associated with cellular proliferation and the percentage of cells in S-phase; however, TS protein is not exclusively associated with S-phase in asynchronously growing cells. The variation in TS levels between exponentially growing and confluent cell population appears to be due to differences in TS levels between G0 and G1 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779704      PMCID: PMC2033861          DOI: 10.1038/bjc.1995.225

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Nucleotide interconversions. II. Elevation of deoxycytidylate deaminase and thymidylate synthetase in regenerating rat liver.

Authors:  F MALEY; G F MALEY
Journal:  J Biol Chem       Date:  1960-10       Impact factor: 5.157

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  A human cell line from a pleural effusion derived from a breast carcinoma.

Authors:  H D Soule; J Vazguez; A Long; S Albert; M Brennan
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Thymidylate synthetase activity in cultured mammalian cells.

Authors:  A H Conrad
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

6.  Catalytic function of thymidylate synthase is confined to S phase due to its association with replitase.

Authors:  G Prem veer Reddy
Journal:  Biochem Biophys Res Commun       Date:  1982-12-15       Impact factor: 3.575

7.  An isotopic assay for thymidylate synthetase.

Authors:  D Roberts
Journal:  Biochemistry       Date:  1966-11       Impact factor: 3.162

8.  Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase.

Authors:  R G Moran; C P Spears; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

9.  Regulation of thymidylate synthetase in mouse leukemia cells (L1210).

Authors:  W Rode; K J Scanlon; B A Moroson; J R Bertino
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

10.  Regulation of thymidylate synthetase activity in cultured mammalian cells.

Authors:  A H Conrad; F H Ruddle
Journal:  J Cell Sci       Date:  1972-03       Impact factor: 5.285

View more
  10 in total

1.  Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up.

Authors:  Silke Lassmann; Michael Hennig; Robert Rosenberg; Jörg Nährig; Joachim Schreglmann; Friedemann Krause; Manuela Poignee-Heger; Hjalmar Nekarda; Heinz Höfler; Martin Werner
Journal:  Int J Colorectal Dis       Date:  2005-08-13       Impact factor: 2.571

2.  Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.

Authors:  Christiane Jakob; Torsten Liersch; Wolfdietrich Meyer; Heinz Becker; Gustavo-B Baretton; Daniela-E Aust
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

3.  Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines.

Authors:  M Derenzini; L Montanaro; D Treré; A Chillà; P L Tazzari; F Dall'Olio; D Ofner
Journal:  Mol Pathol       Date:  2002-10

4.  Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.

Authors:  Tracey L H Jason; Randal W Berg; Mark D Vincent; James Koropatnick
Journal:  Gene Expr       Date:  2007

5.  Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients.

Authors:  A Paradiso; G Simone; S Petroni; B Leone; C Vallejo; J Lacava; A Romero; M Machiavelli; M De Lena; C J Allegra; P G Johnston
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

6.  Proteomics of Sentinel Lymph Nodes in Early Breast Cancer for Identification of Thymidylate Synthase as a Potential Biomarker to Flag Metastasis: A Preliminary Study.

Authors:  Sheetal Pathania; Mohd Imran Khan; Abhishek Kumar; Ashish Kumar Gupta; Komal Rani; Tanvi Ramesh Parashar; Jnaneshwari Jayaram; Piyush Ranjan Mishra; Anurag Srivastava; Sandeep Mathur; Smriti Hari; Gururao Hariprasad
Journal:  Cancer Manag Res       Date:  2020-06-23       Impact factor: 3.989

7.  CHIP E3 ligase mediates proteasomal degradation of the proliferation regulatory protein ALDH1L1 during the transition of NIH3T3 fibroblasts from G0/G1 to S-phase.

Authors:  Qasim A Khan; Peter Pediaditakis; Yuryi Malakhau; Amin Esmaeilniakooshkghazi; Zahra Ashkavand; Valentin Sereda; Natalia I Krupenko; Sergey A Krupenko
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

8.  Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity.

Authors:  J F Mirjolet; M Barberi-Heyob; J L Merlin; S Marchal; M C Etienne; G Milano; P Bey
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

9.  Expression of thymidylate synthase in human cells is an early G(1) event regulated by CDK4 and p16INK4A but not E2F.

Authors:  B G Le François; J A Maroun; H C Birnboim
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

10.  Relationship between protein levels and gene expression of dihydropyrimidine dehydrogenase in human tumor cells during growth in culture and in nude mice.

Authors:  T Takechi; H Okabe; A Fujioka; Y Murakami; M Fukushima
Journal:  Jpn J Cancer Res       Date:  1998-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.